杂志简称：hum gene ther
中文译名：《人类基因治疗》
收录属性：scie（2024版）, 目次收录（维普）,英文期刊,
自引率：4.40%
投稿方向：医学、biotechnology & applied microbiology 生物工程与应用微生物、genetics & heredity 遗传学、medicine, research & experimental 医学、研究与实验
SCI/E期刊基本信息
出版周期：半月刊 地区：美国
中科院分区：3区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN1043-0342；EISSN1557-7422
杂志语言：英语
出版国家：美国
杂志官网 联系方式
出版地址：MARY ANN LIEBERT INC,140 HUGUENOT STREET,3RD FL,NEW ROCHELLE,USA,NY,10801
杂志邮箱：
投稿网址：https://mc.manuscriptcentral.com/hum
杂志官方网址：https://home.liebertpub.com/publications/human-gene-therapy/19/
出版商网址：http://www.liebertpub.com/
杂志投稿要求
投稿须知【杂志社官方网站信息】
Human Gene Therapy
For Authors
Journal Information
Manuscript Submission Site: https://mc.manuscriptcentral.com/hum
Editorial Office Contact: HGT-EO@liebertpub.com
Support Contact: prosupport@liebertpub.com
Journal Model: Hybrid
Blinding: Single Blind
File formatting requirement stage: On revision. Format neutral on original submission.
Instant Online Option (immediate publication of accepted version): Yes
Submission Fee: None
Average time to initial decision: 21 days
About the Journal
Human Gene Therapy will consider manuscripts of very high quality that broadly fall under the scope of cell and gene therapy. Some general categories include studies evaluating novel approaches of cell and gene therapy in pre-clinical and clinical models; development of novel technologies; studies that help define mechanisms of action of cell and gene therapies; host interactions to vector and transplanted cells; and high-impact new methods and clinical trials.
Manuscripts on these topics may be submitted in the form of an original research article or a high impact protocol. Invited review articles and commentaries are usually solicited by the Editorial Board, but we also welcome unsolicited submissions of this type.
The Editors may quickly reject a manuscript soon after submission without external review if it falls outside the scope of the Journal or would not likely meet our high standards required for publication.
Manuscript Types and Guidelines
Original Research Articles
3,000-word limit
Unstructured abstract of no more than 300 words
Maximum of six (6) tables and/or figures
Review Articles
5,000-8,000-word limit
Unstructured abstract of no more than 300 words
Maximum of four (4) tables and/or figures
A maximum of 50 references is permitted
Research Articles- Methods
3,000-word limit
Unstructured abstract of no more than 300 words
Maximum of six (6) tables and/or figures
Research Articles – Clinical Development
3,000-word limit
Unstructured abstract of no more than 300 words
Maximum of six (6) tables and/or figures
Methods Protocols
3,000-word limit
Unstructured abstract of no more than 100 words
Maximum of six (6) tables and/or figures
Clinical Protocols
4,500-word limit
Unstructured abstract of no more than 300 words
Maximum of six (6) tables and/or figures
Pathways in Gene Therapy
2,000-word limit
No abstract
Maximum of two (2) tables and/or figures
Commentaries
1,200-word limit
No abstract
No tables or figures
News and Views
1,000-word limit
No abstract
No tables or figures
Letters to the Editor
500-word limit
May include one figure OR table
Reference citations are identical in style to those of full original articles, but should not exceed five (5).
Word limits do NOT pertain to the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, or references.
Human Gene Therapy welcomes format-neutral manuscripts for first-time submissions. Newly submitted manuscripts will not be un-submitted for formatting issues. However, after the initial peer review process, revised submissions must follow correct journal formatting and file guidelines, as described below in the Instructions for Authors. Please note that there are certain compulsory elements (i.e.: IRB approvals, author disclosures, etc.) that must be included in all new submissions. Manuscripts submitted without this information will be un-submitted and the submitting author will be asked to add the required components.